172 filings
Page 4 of 9
8-K
mif7e e975wyhkh4hz
9 Mar 21
Trevena, Inc. Reports Fourth Quarter and Full Year 2020 Results
7:02am
8-K
2166vx7h lygho6556
11 Feb 21
Other Events
5:01pm
8-K
ssa 1rqewllj3trv9ed
31 Dec 20
Entry into a Material Definitive Agreement
4:31pm
8-K
67qk9n7 4emwpt4y4
2 Nov 20
Regulation FD Disclosure
9:22am
8-K
rncym
30 Oct 20
Trevena, Inc. Announces DEA Scheduling of OLINVYK™ (oliceridine) injection
8:00am
8-K
rfjtkodsc3rm
13 Aug 20
Trevena Announces Pricing of $50 Million Public Offering of Common Stock
12:00am
8-K
tc21my 7dnl
11 Aug 20
Trevena Announces Proposed Public Offering of Common Stock
4:28pm
8-K
f8q6og2
10 Aug 20
Trevena Announces FDA Approval of OLINVYK™ (oliceridine) injection
6:24am
8-K
man7axkmwakko0ndh 8y
2 Jun 20
Trevena Announces Collaboration with Imperial College London to Evaluate TRV027 in COVID-19 Patients
7:00am
8-K
iawqk4r
26 May 20
Other Events
4:05pm
8-K
cfpb7zbv ac9bc6p
18 May 20
Regulation FD Disclosure
5:21pm
8-K
dx3m4ph9g79 9h
18 May 20
Regulation FD Disclosure
7:00am
8-K
o1a8pl f5elengw8
15 May 20
Submission of Matters to a Vote of Security Holders
4:07pm
8-K
wd1dqcc
7 May 20
Trevena Reports First Quarter 2020 Results
7:05am
8-K
5lwfmgflet p3q
20 Apr 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:30am
8-K
chsj1v7qixfceuhfwb
26 Mar 20
Other Events
7:00am
8-K
n96nnzjieve1
13 Mar 20
Trevena Reports Fourth Quarter and Full Year 2019 Results
7:00am
8-K
vjr8f1 3tcg
5 Mar 20
FDA considers NDA resubmission a complete Class 2 response
7:05am
8-K
ydnj g2bp
4 Mar 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
qbwbvhdi
14 Feb 20
Trevena Appoints Scott Applebaum as Chief Legal and Compliance Officer and SVP of Regulatory Affairs
4:02pm